India developed its first indigenous antibiotic

• India has developed the first indigenous antibiotic ‘Naphithromycin’.

• Naphithromycin is designed to treat both typical and atypical drug-resistant bacteria.

• It is developed by ‘Wockhardt’ in collaboration with Biotechnology Industry Research Assistance Council (BIRAC).

• It is the first drug of its class to be introduced globally in over 30 years.

• It is primarily intended to combat community-acquired bacterial pneumonia (CABP), a deadly infection.

• The drug is currently awaiting final manufacturing approval from the Central Drugs Standard Control Organisation (CDSCO).